Table 4 Univariate Cox analysis of prognostic factors associated with survival for diabetic patients with locally advanced cervical cancer who underwent neoadjuvant chemotherapy and radical hysterectomy

1.00

0.96–1.04

0.875

1.01

0.97–1.05

0.681

0.99

0.96–1.03

0.698

1.17

0.99–1.39

0.065

1.18

1.00–1.39

0.055

1.08

0.92–1.26

0.361

1.00

0.98–1.02

0.872

1.02

0.99–1.04

0.211

1.01

0.98–1.03

0.610

2.04

1.07–3.90

0.031

1.85

0.96–3.57

0.065

1.44

0.82–2.54

0.207

1.31

0.62–2.77

0.485

1.27

0.58–2.80

0.549

1.40

0.71–2.76

0.332

0.79

0.19–3.30

0.751

0.90

0.22–3.76

0.888

1.07

0.33–3.44

0.913

1.49

0.62–3.58

0.371

1.55

0.68–3.55

0.300

1.79

0.86–3.70

0.119

1.16

0.61–2.24

0.647

1.26

0.65–2.44

0.503

0.96

0.54–1.70

0.890

3.69

1.71–7.97

0.001

4.14

1.88–9.13

<0.0001

3.04

1.42–6.47

0.004

4.81

2.19–10.56

<0.0001

4.12

1.87–9.07

<0.0001

3.07

1.63–5.78

<0.0001

5.55

2.27–13.55

<0.0001

4.76

1.95–11.59

0.001

3.71

1.55–8.89

0.003

2.24

1.08–4.63

0.030

2.45

1.15–5.22

0.020

2.17

1.15–4.11

0.017

0.90

0.46–1.77

0.763

0.94

0.47–1.86

0.854

0.90

0.50–1.62

0.723

0.61

0.22–1.73

0.355

0.51

0.18–1.46

0.211

0.68

0.30–1.52

0.343

0.77

0.34–1.75

0.531

0.79

0.33–1.90

0.595

1.22

0.62–2.40

0.563

0.56

0.29–1.07

0.077

0.49

0.25–0.94

0.033

0.74

0.41–1.33

0.316